Singapore markets close in 4 hours 21 minutes

Straits Times Index
3,313.81
-9.39(-0.28%)
Nikkei
38,090.98
-465.89(-1.21%)
Hang Seng
18,252.32
-224.69(-1.22%)
FTSE 100
8,183.07
-71.11(-0.86%)
Bitcoin USD
68,264.99
-541.50(-0.79%)
CMC Crypto 200
1,463.01
-21.68(-1.46%)

BMY May 2025 80.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.0800

0.0000

(0.00%)

As of 01:45PM EDT. Market open.

Zacks
Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
Prothena (PRTA) announces that Bristol Myers is exercising its option for the second time, thereby in-licensing exclusive global rights for PRX019 to potentially treat neurodegenerative diseases.
Business Wire
Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma
PRINCETON, N.J., May 29, 2024--Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line...
Business Wire
Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications, Demonstrating Long-Term Survival, and Highlighting Novel Modalities and Research Platforms
PRINCETON, N.J., May 23, 2024--Bristol Myers Squibb to Present Data at ASCO & EHA from More Than 130 Studies Across 25 Diseases Supporting Expansion into New Indications....